相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
Matth S. L. Becker et al.
DIABETES (2009)
Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
I. S. Song et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin
T. J. Urban et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics
Y. Shu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1)
Anne T. Nies et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele*3 independently affect torsemide pharmacokinetics and pharmacodynamics
S. V. Vormfelde et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The functional consequences of genetic variations in transporter genes encoding human organic anion-transporting polypeptide family members
Annick Seithel et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Copy-number variation in control population cohorts
Dalila Pinto et al.
HUMAN MOLECULAR GENETICS (2007)
Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications
Hermann Koepsell et al.
PHARMACEUTICAL RESEARCH (2007)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Pax transactivation-domain interacting protein is required for urine concentration and osmotolerance in collecting duct epithelia
Doyeob Kim et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population
Ho-Jin Kang et al.
DRUG METABOLISM AND DISPOSITION (2007)
Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
Eriko Shikata et al.
JOURNAL OF HUMAN GENETICS (2007)
Global variation in copy number in the human genome
Richard Redon et al.
NATURE (2006)
Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters
Stefan V. Vormfelde et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Characterization of regulatory mechanisms and states of human organic cation transporter
J Biermann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
A human transporter protein that mediates the final excretion step for toxic organic cations
M Otsuka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation
G Ciarimboli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Metformin transport by renal basolateral organic cation transporter hOCT2
N Kimura et al.
PHARMACEUTICAL RESEARCH (2005)
Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta
D Kobayashi et al.
DRUG METABOLISM AND DISPOSITION (2005)
Transporters and drug therapy: Implications for drug disposition and disease
RH Ho et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions
T Sakata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: The Framingham Heart Study
CS Fox et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Functional variants of OCTN cation transporter genes are associated with Crohn disease
VD Peltekova et al.
NATURE GENETICS (2004)
Estimating the contribution of genes and environment to variation in renal drug clearance
MK Leabman et al.
PHARMACOGENETICS (2003)
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1
Y Shu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Involvement of organic cation transporter 1 in the lactic acidosis caused bv metformin
DS Wang et al.
MOLECULAR PHARMACOLOGY (2003)
A comparison of Bayesian methods for haplotype reconstruction from population genotype data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine
CP Zamber et al.
PHARMACOGENETICS (2003)
Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)
A Lazar et al.
JOURNAL OF HUMAN GENETICS (2003)
Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences
R Kerb et al.
PHARMACOGENETICS (2002)
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
DS Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2)
MJ Dresser et al.
PHARMACEUTICAL RESEARCH (2002)
Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function
MK Leabman et al.
PHARMACOGENETICS (2002)
Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene
JW Jonker et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
A new statistical method for haplotype reconstruction from population data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
分享论文
